• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 105306
Device Problem Mechanical Problem (1384)
Patient Problems Thrombosis (2100); Thrombosis/Thrombus (4440)
Event Date 12/01/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient may have a non-occlusive thrombus in the outflow graft on the computer tomography angiography (cta).
 
Manufacturer Narrative
Manufacturer's investigation conclusion: the report of a non-occlusive thrombus in the outflow graft could not be confirmed through this evaluation.It was reported that there was an incidental finding of a possible non-occlusive thrombus in the outflow graft through a computed tomography angiography (cta) scan.The submitted log file contained approximately 11 days of data.No hazard alarms were observed within the file.The pump remained above the low speed limit for the duration of the file.The pump appeared to be functioning as intended.The account later communicated that the thrombus could not be confirmed.The patient remains ongoing on heartmate ii left ventricular assist system (lvas), serial number (b)(6).No further related events have been reported at this time.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu), is currently available.Section 1 of this ifu lists device thrombosis as an adverse event that may be associated with the use of the heartmate ii left ventricular assist system.This ifu outlines indications of pump thrombosis as well as how to respond to such events.Section 6 also outlines the suggested anticoagulation regimen and international normalized ratio (inr) range that should be maintained for patients using the heartmate ii lvas.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 04feb2013.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11057018
MDR Text Key223181806
Report Number2916596-2020-06058
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 01/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2014
Device Model Number105306
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age84 YR
Patient Weight79
-
-